REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Alergosan Sp. z o.o. (Poland)

Main Activities: General Medical and Surgical Hospitals
Full name: Alergosan Sp. z o.o. Profile Updated: May 21, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Alergosan Sp. z o.o. is a company in Poland, with a head office in Koszalin. The enterprise currently operates in the General Medical and Surgical Hospitals sector. It was incorporated on May 18, 2016. It currently has a total number of 1 (2016) employees. In 2023, the company reported a net sales revenue increase of 9.28%. A growth of 57.93% was recorded in its total assets. In, 2023, the company’s net profit margin increased by 5.56%.

Headquarters
Ul. Warminska 5
Koszalin; Zachodniopomorskie; Postal Code: 75-393

Contact Details: Purchase the Alergosan Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Alergosan Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Alergosan Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Alergosan Sp. z o.o. report to view the information.
Incorporation Date:
May 18, 2016
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
45%
Company Performance
Financial values in the chart are available after Alergosan Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
9.28%▲
Total operating revenue
9.28%▲
Operating profit (EBIT)
27.11%▲
EBITDA
26.45%▲
Net Profit (Loss) for the Period
39.7%▲
Total assets
57.93%▲
Total equity
90.44%▲
Operating Profit Margin (ROS)
3.58%▲
Net Profit Margin
5.56%▲
Return on Equity (ROE)
-19.17%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo